英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
Zardaverine
|
101975-10-4 |
扎达维林
|
6-[4-(二氟甲氧基)-3-甲氧基苯基]-3(3H)-哒嗪酮;扎达维林
|
C12H10F2N2O3 |
268.22 | |
Y 27632 di hydrochloride
|
129830-38-2 |
Y27632 (HYDROCHLORIDE)
|
Y-27632二盐酸盐, 一种选择性ROCK1(P160ROCK)抑制剂;反式-4-[(R)-1-氨基乙基]-N-(4-吡啶基)环己烷甲酰胺二盐酸盐
|
C14H23Cl2N3O |
320.25792 | 813-428-5 |
BMS-863233 (XL-413)
|
1169562-71-3 |
XL413 (BMS-863233)
|
8-氯-2-(2S)-2-吡咯烷基苯并呋喃并[3,2-D]嘧啶-4(3H)-酮盐酸盐;XL413(BMS-863233);CS-1062;BMS-863233;BMS863233;BMS 863233;XL-413;XL413;XL 413.;XL413.HCL
|
C14H13Cl2N3O2 |
326.17792 | |
XL 019
|
945755-56-6 |
XL019
|
XL019;XL-019;XL 019.;XL019>95%;(S)-N-(4-(2-(4-MORPHOLINOPHENYLAMINO)PYRIMIDIN-4-YL)PHENYL)PYRROLIDINE-2-CARBOXAMIDE;(2S)-N-[4-[2-[[4-(4-吗啉基)苯基]氨基]-4-嘧啶基]苯基]-2-吡咯烷甲酰胺
|
C25H28N6O2 |
444.52882 | |
Wnt-C59-C59
|
1243243-89-1 |
1G;5G;10G;25G;500G
|
WNT C59;C59;WNTC59;CS-876;4-(2-甲基-4-吡啶基)-N-[4-(3-吡啶基)苯基]苯乙酰胺;2-(4-(2-甲基吡啶-4-基)苯基)-N-(4-(吡啶-3-基)苯基)乙酰胺;2-[4-(4-(2-甲基吡啶)苯基]-N-(4-(3-吡啶)苯基)-乙酰胺;WNT-C59 (C59);WNT C59;C59;WNT-C59,一种有效的PORCN 酶活性和 WNT抑制剂
|
C25H21N3O |
379.45374 | |
VX-745
|
209410-46-8 |
VX-745
|
CS-1918;NEFLAMAPIMOD;VX 745;VX-745游离态;5-(2,6-二氯苯基)-2-((2,4-二氟苯基)硫基)-6H-嘧啶并[1,6-B]哒嗪-6-酮;209410-46-8;5-(2,6-B]哒嗪-6-酮(VX745);5-(2,6-b]哒嗪-6-酮
|
C19H9Cl2F2N3OS |
436.26 | |
VidofludiMus
|
717824-30-1 |
VIDOFLUDIMUS(4SC-101; SC12267)
|
|
C20H18FNO4 |
355.359623 | 615-418-4 |
5'-O-[(4-Cyanophenyl(methyl]-8-[[(3,4-dichlorophenyl(methyl]amino]-adenosine
|
1134156-31-2 |
VER 155008
|
CS-1647;VER 155008;VER-155008;VER155008;5'-O-[(4-氰基苯基(甲基]-8-[[(3,4-二氯苯基(甲基]氨基]腺苷
|
C25H23Cl2N7O4 |
556.40062 | |
Cyclohexyl [1,1'-biphenyl]-3-ylcarbamate
|
565460-15-3 |
3-(环已氧羰基胺基)联苯
|
URB 602;URB-602;[1,1'-联苯]-3-基氨基甲酸环己酯;3-(环已氧羰基胺基)联苯
|
C19H21NO2 |
295.38 | |
UNC0638
|
1255580-76-7 |
UNC0638
|
CS-565;2-环己基-6-甲氧基-N-[1-异丙基-4-哌啶基]-7-[3-(1-吡咯烷基(丙氧基]-4-喹唑啉胺
|
C30H47N5O2 |
509.72648 | |
UNC0379
|
1620401-82-2 |
UNC0379
|
CS-1767;6,7-二甲氧基-2-(1-吡咯烷基)-N-[5-(1-吡咯烷基)戊基]-4-喹唑啉胺;UNC 0379;UNC-0379
|
C23H35N5O2 |
413.57 | |
UNC 0224
|
1197196-48-7 |
UNC 0224
|
7-[3-(二甲基氨基)丙氧基]-2-(六氢-4-甲基-1H-1,4-二氮杂卓-1-基)-6-甲氧基-N-(1-甲基-4-哌啶基)-4-喹唑啉胺
|
C26H43N7O2 |
485.66532 | |
UK-383367
|
348622-88-8 |
UK 383367
|
5-[(1R)-4-环己基-1-[2-(羟基氨基)-2-氧代乙基]丁基]-1,2,4-恶二唑-3-甲酰胺;UK-383367 (UK 383367)
|
C15H24N4O4 |
324.37546 | |
UK 356618 - PF 03890101
|
230961-08-7 |
UK 356618
|
UK 356618 - PF 03890101;N1-[(1S)-2,2-Dimethyl-1-[[[(1R)-1-phenylethyl]amino]carbonyl]propyl]-N4-hydroxy-2-[3-(2-methyl[1,1'-biphenyl]-4-yl)propyl]-butanediamine;UK 356618;(2R)-N1-[(1S)-2,2-DiMethyl-1-[[[(1R)-1-phenylethyl]aMino]carbonyl]propyl]-N4-hydroxy-2-[3-(2-Methyl[1,1'-biphenyl]-4-yl)propyl]butanediaMide;PF-03890101;(2R)-N1-[(1S)-2,2-Dimethyl-1-({[(1R)-1-phenylethyl]amino}carbonyl)propyl]-2-{3-[(3-methyl-4-phenyl)-phenyl]propyl}-(N4-hydroxy)butanediamide
|
|||
TWS119
|
601514-19-6 |
TWS119
|
|
C18H14N4O2 |
318.335 | |
TTP 22
|
329907-28-0 |
TTP 22
|
3-(5-P-TOLYLTHIENO[2,3-D]PYRIMIDIN-4-YLTHIO)PROPANOIC ACID;3-[[5-(4-甲基苯基)噻吩并[2,3-D]嘧啶-4-基]硫代]丙酸;TTP22;TTP-22;CS-886;TTP 22>97%
|
C16H14N2O2S2 |
330.42456 | |
Trovafloxacin mesylate
|
147059-75-4 |
TROVAFLOXACIN MESYLATE
|
曲伐沙星甲磺酸;曲伐沙星甲磺酸盐
|
C20H15F3N4O3 |
512.45896 | |
Torin 1
|
1222998-36-8 |
Torin 1
|
TORIN-1;TORIN 1;CS-1958;1-[4-[4-(1-氧代丙基(-1-哌嗪基]-3-(三氟甲基(苯基]-9-(3-喹啉基(苯并[H]-1,6-萘啶-2(1H(-酮;1-[4-[4-(1-氧代丙基(-1-哌嗪基]-3-(三氟甲基(苯基]-9
|
C35H28F3N5O2 |
608 | |
Toloxatone
|
29218-27-7 |
涛洛西酮
|
托洛沙酮;涛洛西酮;托洛沙酮;5-羟甲基-3-(3-甲基苯基)噁唑烷-2-酮;多劳喜动;5-(羟甲基)-3-(M-甲苯基)恶唑烷-3-酮
|
C11H13NO3 |
207.23 | 249-522-2 |
TMS
|
24144-92-1 |
2,3',4,5'-四甲氧基二苯乙烯
|
5'-四甲氧基二苯乙烯;2,3',4,5'-四甲氧基二苯乙烯;CS-961
|
C18H20O4 |
300.35 | 607-328-9 |